Syndax Pharmaceuticals grants inducement awards for up to 175,000 shares
Syndax Pharmaceuticals announced inducement grants under NASDAQ Listing Rule 5635(c)(4) on Sept. 1, 2026, to purchase up to 175,000 shares of common stock.
NEW YORK, Sept.
04, 2026 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals NASDAQ:SNDX, a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that on September 1, 2026, the Company granted inducement awards to purchase up to 175,000 shares of common stock to n…